Physicians are impressed with both the rapid response by Week 4 and the diversity of etiologies responding to KSI-101 115 “... It’s not much different than using anti-VEGF to treat DME, AMDs, and RVOs . Those are very different diseases with very different pathophysiology but at the end of the day the medicine is the same and it works well in all three diseases . [...] I didn't see that before—but seeing these pictures and seeing the data that you showed me on the slide I don't see a reason not to....” – Retinal Specialist